IBDEI11G ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16879,0)
 ;;=J11.1^^61^777^47
 ;;^UTILITY(U,$J,358.3,16879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16879,1,3,0)
 ;;=3^Influenza d/t Unident Influenza Virus w/ Oth Resp Manifest
 ;;^UTILITY(U,$J,358.3,16879,1,4,0)
 ;;=4^J11.1
 ;;^UTILITY(U,$J,358.3,16879,2)
 ;;=^5008158
 ;;^UTILITY(U,$J,358.3,16880,0)
 ;;=N12.^^61^777^92
 ;;^UTILITY(U,$J,358.3,16880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16880,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,16880,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,16880,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,16881,0)
 ;;=N11.9^^61^777^93
 ;;^UTILITY(U,$J,358.3,16881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16881,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis,Chronic
 ;;^UTILITY(U,$J,358.3,16881,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,16881,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,16882,0)
 ;;=N13.6^^61^777^78
 ;;^UTILITY(U,$J,358.3,16882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16882,1,3,0)
 ;;=3^Pyonephrosis
 ;;^UTILITY(U,$J,358.3,16882,1,4,0)
 ;;=4^N13.6
 ;;^UTILITY(U,$J,358.3,16882,2)
 ;;=^101552
 ;;^UTILITY(U,$J,358.3,16883,0)
 ;;=N30.91^^61^777^22
 ;;^UTILITY(U,$J,358.3,16883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16883,1,3,0)
 ;;=3^Cystitis w/ Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,16883,1,4,0)
 ;;=4^N30.91
 ;;^UTILITY(U,$J,358.3,16883,2)
 ;;=^5015643
 ;;^UTILITY(U,$J,358.3,16884,0)
 ;;=N30.90^^61^777^23
 ;;^UTILITY(U,$J,358.3,16884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16884,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,16884,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,16884,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,16885,0)
 ;;=N41.9^^61^777^41
 ;;^UTILITY(U,$J,358.3,16885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16885,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,16885,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,16885,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,16886,0)
 ;;=N70.91^^61^777^80
 ;;^UTILITY(U,$J,358.3,16886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16886,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,16886,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,16886,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,16887,0)
 ;;=N70.93^^61^777^79
 ;;^UTILITY(U,$J,358.3,16887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16887,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,16887,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,16887,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,16888,0)
 ;;=N70.92^^61^777^58
 ;;^UTILITY(U,$J,358.3,16888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16888,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,16888,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,16888,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,16889,0)
 ;;=N73.9^^61^777^40
 ;;^UTILITY(U,$J,358.3,16889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16889,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,16889,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,16889,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,16890,0)
 ;;=A56.11^^61^777^39
 ;;^UTILITY(U,$J,358.3,16890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16890,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,16890,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,16890,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,16891,0)
 ;;=N73.5^^61^777^67
 ;;^UTILITY(U,$J,358.3,16891,1,0)
 ;;=^358.31IA^4^2
